BEGIN:VCALENDAR VERSION:2.0 PRODID:-//ESACT-UK - ECPv6.15.13.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:ESACT-UK X-ORIGINAL-URL:https://www.esactuk.org.uk X-WR-CALDESC:Events for ESACT-UK REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:Europe/London BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:BST DTSTART:20250330T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:GMT DTSTART:20251026T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:BST DTSTART:20260329T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:GMT DTSTART:20261025T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:BST DTSTART:20270328T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:GMT DTSTART:20271031T010000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;VALUE=DATE:20260107 DTEND;VALUE=DATE:20260109 DTSTAMP:20260507T133314 CREATED:20250528T095044Z LAST-MODIFIED:20260108T101526Z UID:5041-1767744000-1767916799@www.esactuk.org.uk SUMMARY:36th Annual Meeting ESACT-UK 2026 DESCRIPTION:« All Events\n \n \n \n \n This event has passed. \n \n \n \n \n \n \n \n \n \n \n 36th Annual Meeting ESACT-UK 2026 \n \n \n \n \n \n January 7\n\n \n \n - \n\n January 8\n\n \n \n \n \n \n The ESACT-UK 2026 Conference will be held in-person over the 7th and 8th January 2026 at Leonardo Royal Hotel Oxford (Formerly Jurys Inn)\, Oxford UK. \n \n \n \n \n \n \n \n \n \n \n \n Event Sponsors \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Sponsorship booking now open \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n\n \n \n \n \n Conference Overview \n \n \n \n Early-career Researcher \n \n \n \n Sponsorships \n \n \n \n Delegates \n \n \n\n \n \n \n Join us for the ESACT-UK 2026 Conference that will be held on the 7th and 8th January 2026 in Oxford\, UK. You can expect high-profile speakers such as Dr. Ioscani Jimenez del Val (UCD)\, Dr. Yusuf Johari (Lonza)\, Prof Gary Lye (UCL) and Prof. David James (University of Sheffield)\, and exciting talks across sessions\, covering engineering biology platforms\, integration of AI/ML in bioprocess development\, translational bioprocessing\, training in bioprocessing and biopharmaceutical development & manufacturing\, We will also be showcasing the work of our early career researchers\, followed by a panel session focussing on the use of AI in biomanufacturing. \nTo book your ticket for this event\, please go to the ‘Delegates’ tab. \n Speakers Prof Gary Lye (UCL)Professor of Biochemical EngineeringDr James Budge (University of Kent)Lecturer / CHRSA Winner 2025Dr Alexander Douglas (University of Oxford)Associate ProfessorDr Francesca Ceroni (Imperial College London)Senior LecturerDr Ioscani Jimenez del Val (University College Dublin) Associate ProfessorDr Yusuf Johari (Lonza)Principal ScientistLouis Frost (OXB)Senior ScientistDr Pietro Sormanni (Imperial College London)Associate ProfessorProf Daniel Ungar (University of York)ProfessorDr Stephen Goldrick (UCL)LecturerDr Eva Antonopoulou (FUJIFILM Biotechnologies)ScientistProf David James (Syngensys)Co-founderDr Will Milligan (Extracellular)CEODr Dave Mentlak (Mesenbio)Senior ScientistDr Emma Hargreaves (University of Kent)Senior Lecturer \n \n \n \n \n \n \n \n \n \n \n \n \n \n Gary Lye\, UCL\n \n Biography:Gary Lye is a Professor of Biochemical Engineering at University College London (UCL) and the Director of the UCL East Manufacturing Futures Lab (MFL). He has broad research interests related to the rapid design\, optimisation and scale-up of bio-based manufacturing processes. He is also the Co-Director of the EPSRC Cellular Agriculture Manufacturing Hub (CARMA) and is one of the leads of the EPSRC Future Biomanufacturing Research Hub (FBRH). He has a particular interest in how bioprocess skills develop in his capacity as Director of the EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership and Co-Director of the recently funded Innovate UK Medicines Manufacturing Skills Centre of Excellence (RESILIENCE). \n \n \n \n \n \n \n \n James Budge\, University of Kent\n \n Biography:James is an academic researcher working at the interface between fundamental biological science and industrial bioprocessing at the University of Kent. After completing his PhD in 2016\, he undertook a variety of post-doctoral positions in Mark Smales’ lab at the university with various collaborators including Lonza Biologics and as part of a consortium Global Challenges Research Fund. Research into the cellular mechanisms involved in upstream manufacturing processes has directly led to granting of three internationally recognised patents in the biotherapeutics field. James also joined the ESACT Frontiers committee in 2024 who provide personal and professional development opportunities for early career scientists. In January 2025 he started his current position as Lecturer in Industrial Biotechnology and is now establishing his group as an independent principal investigator where he will continue to focus on developing tools and bioprocesses to enhance the biotherapeutic field. \n \n \n \n \n \n \n \n Alexander Douglas\, University of Oxford - TBC\n \n TBC \n \n \n \n \n \n \n \n Francesca Ceroni\, Imperial College London\n \n Biography: Francesca graduated in Pharmaceutical Biotechnologies from the University of Bologna and obtained a PhD in Bioengineering from the same university. In 2013 she joined Imperial College London as Research Associate in Synthetic Biology in the groups of Prof. Tom Ellis and Prof. Guy-Bart Stan. Her work aimed at examining the causes of burden in Escherichia coli. In 2016 Francesca was awarded the Junior Research Fellowship of Imperial College London to deepen her interests in mammalian synthetic biology. In October 2018 she was appointed Lecturer and since October 2025 she is Reader (Associate Professor) in Cell Engineering in the Department of Chemical engineering at Imperial. \n \n \n \n \n \n \n \n Ioscani Jimenez del Val\, University College Dublin\n \n Title: Glyvantis Bio: Precision control of mAb glycosylation for optimal therapeutic efficacy Biography: Ioscani leads the Animal Cell Technology Group (ACTG) at the School of Chemical & Bioprocess Engineering\, University College Dublin. ACTG is a multidisciplinary team that integrates advanced experimentation (synthetic biology tools) and computational strategies (hybrid modelling) to optimise the production of biopharmaceuticals. Ioscani graduated with a BE in Chemical Engineering from the National Autonomous University of Mexico (UNAM) in 2006 and received his PhD from Imperial College London in 2013. Before joining UCD in 2014\, he worked as a Postdoctoral researcher with Prof Cleo Kontoravdi and Prof Karen Polizzi at Imperial. \n \n \n \n \n \n \n \n Yusuf Johari\, Lonza\n \n Title: Accelerated generation of monoclonal and bispecific antibodies via a production-phase promoter and MSX-free process Biography: Yusuf Johari is a Senior Principal Scientist at Lonza R&D\, Cambridge\, where he leads a research team dedicated to advancing expression vector technologies to enhance bioproduction performance in CHO cells. With over 15 years of experience in bioprocessing research across academia and industry\, Yusuf brings deep expertise in DNA engineering and cell line development. He holds a PhD from the University of Sheffield. \n \n \n \n \n \n \n \n Louis Frost\, Senior Scientist\, Oxford Biomedica\n \n Title: HIV-1 Packaging Cell Lines: Bridging the gap from Transient production to stable producer cell lines Biography: Louis Frost is a Senior Scientist at OXB with eight years of experience in cell and gene therapy. He began his career in the Cell Engineering Group\, where he developed basal\, packaging\, and producer cell lines for a variety of viral vectors\, and supported the implementation of automated cell line development technologies. Currently\, Louis is part of Process Development Department\, where he onboards clients’ products using OXB’s platform and technologies. Louis’s work spans the full biologics development journey\, and he is passionate about translating scientific innovation into impactful therapies for patients. \n \n \n \n \n \n \n \n Pietro Sormanni\, Imperial College London\n \n Title: Antibody discovery and engineering by computational design Biography: Pietro Sormanni is a Royal Society University Research Fellow leading a group at Imperial College London (previously at the University of Cambridge) and the recipient of the 2025 Norman Heatley Award from the Royal Society of Chemistry. His research lies at the interface of computational method development and experiments. The group’s main goal is to create computational protein-design technologies to transform antibody discovery and engineering. Their work\, also through industrial and academic partnerships\, already shows that these methods can streamline antibody development and deliver faster\, cheaper alternatives to traditional routes. Previously\, Pietro was a Borysiewicz Biomedical Sciences Fellow at Cambridge. He holds a PhD in Chemistry (Cambridge) and an MSc in Theoretical Physics (University of Milan). \n \n \n \n \n \n \n \n Daniel Ungar\, University of York\n \n Title: Computational modelling of glycosylation to tailor therapeutic antibody quality Biography:Following a PhD at the MPI of Biophysics in Frankfurt (Germany)\, Daniel Ungar studied vesicle trafficking in the mammalian Golgi as a PDRA at Princeton University. Once starting his group at the University of York\, he combined the investigation of Golgi cell biology with studying glycans. Currently a Professor of Biochemistry at York\, his group uses a combination of molecular cell biology\, glycan analytics and computational modelling to understand the regulation of glycan biosynthesis in mammalian cells. \n \n \n \n \n \n \n \n Stephen Goldrick\, UCL\n \n Title: Current and Future Digital Trends in Biomanufacturing Biography: Stephen is a Lecturer in Digital Bioprocess Engineering at UCL\, specialising in advanced data analytics and mathematical modelling for bioprocess optimisation. His research develops digital twins and PAT-enabled soft sensors to support real-time monitoring\, predictive control\, and intelligent biomanufacturing. \n \n \n \n \n \n \n \n Evangelina Antonopoulou\, Fujifilm Diosynth Technologies\n \n Title: Use of computational fluid dynamics in bioprocess development and manufacturing Biography:Eva Antonopoulou completed her BSc in Mathematics at the University of the Aegean\, followed by an MSc at Heriot-Watt University and an integrated MSc/PhD in Mathematics and Fluid Dynamics at the University of Leeds. She worked as a Research Associate in Mathematical Biology and Fluid Dynamics at the Mathematical Institute\, University of Oxford\, where she also contributed to college teaching. For the past three years\, she has been applying her expertise to pharmaceutical development at Fujifilm Biotechnologies\, developing mathematical and CFD models to improve biologically driven manufacturing processes. \n \n \n \n \n \n \n \n David James\, Syngensys - TBC\n \n TBC \n \n \n \n \n \n \n \n Will Milligan\, Extracellular\n \n Will Milligan is Founder & CEO of Extracellular\, a scale-up and development partner for novel foods\, materials and cosmetics ingredients. Extracellular supports the rapid commercialisation of products using animal and plant cell culture. Extracellular has established world-leading capabilities in the UK\, with expertise in small-scale optimisation for process development\, high-throughput media development\, and scale-up capabilities to produce large quantities of cell-based products. Will is an biomanufacturing specialist\, with more than a decade of experience in process development and scale-up across stem cells\, gene therapies and non-health biotech products. Will was formerly Head of Upstream Processing at a UK-based biotech CDMO and consultancy and holds an Engineering Doctorate in Biopharmaceutical Process Development. \n \n \n \n \n \n \n \n Dave Mentlak\, Mesenbio\n \n Biography:• Senior Scientist at Mesenbio\, a University of York (UoY) spinout company developing extracellular vesicle (EV) based therapeutics with a focus on regenerative medicine.• 8+ years of post-doctoral research (UoY) aimed at improving antibody production in CHO cells in collaboration with FUJIFILM Diosynth Biotechnologies.• Strong capabilities in cell biology and bioprocessing.• Currently leads the investigation into Mechanism of Action of EV therapeutics.• PhD\, University of Durham \n \n \n \n \n \n \n \n Emma Hargreaves\, University of Kent\n \n Biography:Dr Emma Hargreaves is Director of Education and a Senior Lecturer in the School of Natural Sciences at the University of Kent. Her research background lies in translational control and industrial biotechnology\, with a particular focus on the regulation of mRNA translation during recombinant protein production in mammalian cells\, and she has over a decade of research experience in this area. Emma serves as an education technology specialist panel member for the Biochemical Society’s Education\, Training and Public Engagement panel. In her current leadership role\, she oversees educational strategy across the School of Natural Sciences\, championing inclusive practice\, academic wellbeing\, and innovation in teaching and learning. More recently\, she has developed a strategic interest in artificial intelligence in education\, contributing to institutional leadership on AI strategy at the University of Kent. She now sits on the University AI Education Strategy Group and leads the School of Natural Sciences AI Strategy Group\, bringing an informed perspective on the opportunities\, limitations\, and ethical considerations of AI for training and workforce development in biotechnology. \n \n \n \n \n \n \n \n \n \n 36th Annual Meeting ESACT-UK 2026Date & TimeJanuary 7 - January 8 LocationLeonardo Royal Hotel Oxford (Formerly Jurys Inn)\, OxfordView in Maps Agenda2026-01-0709:00RegistrationRegistration \n11:00Welcome Note from the ESACT-UK ChairProf Karen Coopman – ESACT-UK Chair \n11:10Session 1: Strategic Perspectives on Biopharmaceutical Development and ManufacturingChair: Peter Archibald (Touchlight) \n11:10-11:15    Sponsor talk: Cytomos11:15–11:55 Keynote: Prof Gary Lye (UCL): Supporting Talent Pipeline Development for an Evolving UK Medicines Manufacturing Sector11:55–12:40  CHRSA Winner 2025  – Dr James Budge (University of Kent)12:40–13:00  Dr Alexander Douglas (University of Oxford) \n13:00LUNCH14:00Session 2: Engineering Biology Platforms for Next-Generation BiomanufacturingChair: Leon Pybus (FUJIFILM Biotechnologies) \n14:00-14:05    Sponsor talk: Atum Bio \n14:05–14:45 Keynote: Prof Francesca Ceroni (Imperial College London)  – Synthetic biology tools for mammalian engineering \n14:45–15:05 Dr Ioscani Jimenez del Val (University College Dublin) – Glyvantis Bio: Precision control of mAb glycosylation for optimal therapeutic efficacy \n15:05–15:25 Dr Yusuf Johari (Principal Scientist\, Lonza) – Accelerated generation of monoclonal and bispecific antibodies via a production-phase promoter and MSX-free process \n15:25–15:45 Mr Louis Frost (OXB) – HIV-1 Packaging Cell Lines: Bridging the gap from Transient production to stable producer cell line \n115:45COMFORT BREAK\, TRADE AND POSTERS16:30Session 3: Early Career Researchers talksChair: Hirra Hussain (CPI) \n16:30 – 16:35     Sponsor talk: Getinge \n16:35 – 16:40     Poster flash #1 – Javiero Bravo Venegas (University of Manchester) \n16:40 – 16:45     Poster flash #2 – Maria Laura Vieri (UCL) \n 16:45 – 16:50     Poster flash #3 – Yunke Zhou (Lonza) \n16:50 – 16:55     Poster flash #4 – Stefan Calota (UCL) \n16:55 – 17:10     ECR #1 Oral – Marta Arrizabalaga Cascallana (UCL) \n17:10 – 17:25     ECR #2 Oral – Ankita Mishra (University of Kent) \n17:25 – 17:40     ECR #3 Oral – William Gordon-Petrovskii (UCL) \n17:40 – 17:55     ECR #4 Oral – Sandeep Mangrati (UCL) \n17:55 – 18:10     ECR #5 Oral – Tamas Jonas Laufer (UCL) \n18:10AGMESACT-UK Chair: Prof Karen Coopman \n18:20Drinks Reception and Networking20:00Conference Dinner2026-01-0808:30Day 2 Introduction 08:35Session 4: Integration of Artificial Intelligence and Machine Learning in Bioprocess DevelopmentChair: Pavlos Kostidis (GSK) \n8:35 – 8:40     Sponsor talk: Nova Biomedical \n08:40–09:20    Keynote: Dr Pietro Sormanni (Imperial College London) – Antibody discovery and engineering by computational design \n09:20–09:40    Prof Daniel Ungar (University of York) – Computational modelling of glycosylation to tailor therapeutic antibody quality \n09:40–10:00    Dr Stephen Goldrick (UCL) – Current and Future Digital Trends in Biomanufacturing \n10:00–10:20    Dr Eva Antonopoulou (FUJIFILM Biotechnologies) – Use of computational fluid dynamics in bioprocess development and manufacturing \n10:20COMFORT BREAK\, TRADE AND POSTERS10:45Session 5: Panel - AI use in biomanufacturing - potential and concerns10:45 – 10:50     Sponsor talk – TCS \n10:50 – 11:50    Panel: “AI use in biomanufacturing — potential and concerns” \nPanel Chair: TBC \nPanellists: \n\nEmma Hargreaves\, University of Kent\nStephen Goldrick\, UCL\nPietro Sormanni\, Imperial College London\nRicky Martin\, Hyper Recruitment Solutions\nIoscani Jimenez del Val\, University College Dublin\n\n11:50Session 6: Translational Bioprocessing — From Laboratory to Commercial ManufacturingChair: Petra Hanga (UCL) \n11:50-11:55    Sponsor talk: SaniSure \n11:55–12:15    Prof David James (Co-founder\, Syngensys) – Spinning Out Synthetic Genetic Systems: From Inception to Commercialisation \n12:15–12:35   Dr Dave Mentlak (Senior Scientist\, Mesenbio) – MEV-N01: Developing an extracellular vesicle based therapeutic \n12:35–12:55    Dr Will Milligan (CEO\, Extracellular) \n12:55 Cytomos Prize winner announcement13:00Poster Flash and Oral Presentation Prize giving and Closing Remarks13:10LUNCH \n \n Calling early career researchers (ECRs) to join us for the 36th ESACT-UK annual meeting. This year\, we are looking to maintain an increased proportion of ECRs in the scientific programme\, so if you are an ECR (within 7 years of completing a BSc) and would like to present your work\, please submit a high quality scientific abstract stating your preference for oral presentation\, poster flash or poster. Use this template and upload it in the ‘Contact Us’ tab addressed to the Secretary. \nThe deadline for abstract submission has now been extended to Wednesday\, 12th of November 2025. \nThe ESACT-UK organising committee will review the applications and select candidates for each presentation type. The subjects need to be relevant to cell culture biotechnology in order to be in the remit of ESACT-UK. Committee decision is final. \nAll successful candidates will be awarded a full or partial bursary to attend the 36th ESACT-UK annual meeting. We therefore ask abstract applicants not to register for the meeting at this time. If successful\, you will be given details on the bursary and registration separately. \nAll attending early career researchers will also be eligible for one of the following prizes: \n\nBest presentation – £500 bursary for an event of their choice;\nBest poster flash – £350 bursary for an event of their choice;\nBest poster – £250 bursary for an event of their choice.\n\nThe early career researcher must be a member of the ESACT-UK. Membership is FREE to join for students. More details on how to become a member can be found on our ‘Join us’ page. \nFor any questions about abstract and bursary applications\, please do not hesitate to get in touch via the ‘Contact us’ page by addressing the correspondence to the Secretary. \n \n \n GOLD Sponsor – £3\,000\n(Limited to one sponsor) \nPosition your company as the official sponsor of the ESACT-UK 2026 Conference with our premium Gold package. This exclusive opportunity offers maximum visibility and engagement throughout the event. \nPackage includes: \n\nPrime location within the exhibition area\nDouble exhibition stand space (table-top style; 2 x 6ft tables provided). Please bring an extension lead if multiple power sockets are required\nConference registration for three trade delegates\, including access to all conference presentations\, tea/coffee breaks\, lunches\, and the conference dinner\nFive-minute presentation slot during the pre-dinner session\nSponsorship of a keynote speaker session\nOpportunity to display up to three scientific posters during the poster session (see submission guidelines below)\nFull-page (A4) advert in the digital delegate handbook (to be supplied electronically by 30th November 2025 via our contact page\, selecting ‘Trade’ as the recipient)\nOption to place your marketing materials or corporate gifts on tables in the dinner area (materials to be supplied by your organisation)\nSpace for a flash banner in the reception area and dinner venue (banner to be provided by your organisation)\n\nPoster Submission: \nIf you would like to present a poster\, please submit a scientific abstract via our contact page (select ‘Trade’ as the recipient) by 30th November 2025. Please note: ESACT-UK reserves the right to reject posters that are purely promotional or sales-oriented. \nPlease note: Accommodation is not included in this sponsorship package. \n  \n\nSILVER Sponsor – £2\,250\n(Limited to one sponsor) \nGain prominent visibility at ESACT-UK 2026 as our exclusive Silver Sponsor\, with valuable presentation and branding opportunities throughout the event. \nPackage includes: \n\n1.5x exhibition stand space (table-top style; 1 x 6ft and 1 x 4ft tables provided). Please bring an extension lead if multiple power sockets are required\nConference registration for two trade delegates\, including access to all conference presentations\, tea/coffee breaks\, lunches\, and the conference dinner\nFive-minute presentation slot at the start of the second keynote speaker session\nSponsorship of the second keynote speaker session\nOpportunity to display up to two scientific posters during the poster session (see submission guidelines below)\nHalf-page (A4) advert in the digital delegate handbook (to be submitted electronically by 30th November 2025 via our contact page\, selecting ‘Trade’ as the recipient)\nOption to place your marketing materials or corporate gifts on seats in the presentation room during your sponsored session (materials to be provided by your organisation)\n\nPoster Submission: \nIf you would like to present a poster\, please submit a scientific abstract via our contact page (select ‘Trade’ as the recipient) by 30th November 2025. Please note: ESACT-UK reserves the right to reject posters that are purely promotional or sales-oriented. \nPlease note: Accommodation is not included in this sponsorship package. \n  \n\nBRONZE Sponsor – £1\,300\n(Up to four available) \nShowcase your organisation by sponsoring a conference session at ESACT-UK 2026. This Bronze package offers valuable exposure and the opportunity to engage directly with attendees during your sponsored session. \nPackage includes: \n\nExhibition stand space (table-top style; 1 6ft table provided). Please bring an extension lead if multiple power sockets are required\nConference registration for one trade delegate\, including access to all conference presentations\, tea/coffee breaks\, lunches\, and the conference dinner\nSponsorship of one conference session (session selection available on a first-come\, first-served basis)\nThree-minute presentation slot at the start of your sponsored session\nOpportunity to display one scientific poster during the poster session (see submission guidelines below)\nOne-third page (A4) advert in the digital delegate handbook (to be submitted electronically by 30th November 2025 via our contact page\, selecting ‘Trade’ as the recipient)\nOption to place marketing materials or corporate gifts on the seats in the presentation room for your sponsored session (materials to be supplied by your organisation)\n\nPoster Submission: \nTo display a poster\, please submit a scientific abstract via our contact page (select ‘Trade’ as the recipient) by 30th November 2025. Please note: ESACT-UK reserves the right to reject posters that are primarily promotional or sales-focused. \nPlease note: Accommodation is not included in this sponsorship package. \n  \n\nExhibitor – £900\n(Up to 14 spaces available) \nPromote your organisation at ESACT-UK 2026 with an exhibitor package designed to provide valuable networking opportunities and brand exposure throughout the event. \nPackage includes: \n\nExhibition stand space (table-top style; 1 6ft table provided). Please bring an extension lead if multiple power sockets are required\nConference registration for one trade delegate\, including access to all conference presentations\, tea/coffee breaks\, lunches\, and the conference dinner\nCompany listing in the digital delegate handbook\nOpportunity to display one scientific poster during the poster session (see submission guidelines below)\n\nPoster Submission: \nTo display a poster\, please submit a scientific abstract via our contact page (select ‘Trade’ as the recipient) by 30th November 2025. Please note: ESACT-UK reserves the right to decline posters that are promotional rather than scientific in nature. \nPlease note: Accommodation is not included in this package. \n  \n\nServices Pass – £600\n(Up to 6 available – New for 2026!) \nThis new package is designed specifically for service providers such as consultants\, recruiters\, and software developers who wish to engage with delegates but do not require equipment display space. \nPackage includes: \n\nExhibition stand space (table-top style; one 4ft table provided). Intended for brochures\, flyers\, and printed materials only – no equipment displays permitted\nConference registration for one trade delegate\, including access to all conference presentations\, tea/coffee breaks\, lunches\, and the conference dinner\nCompany listing in the digital delegate handbook\nOpportunity to display one scientific poster during the poster session (see submission guidelines below)\n\nPoster Submission: \nTo display a poster\, please submit a scientific abstract via our contact page (select ‘Trade’ as the recipient) by 30th November 2025. Please note: ESACT-UK reserves the right to reject posters that are promotional rather than scientific in nature. \nPlease note: Accommodation is not included in this package. \n  \n\nAdditional Exhibitor Pass – £275\n(Up to 25 available) \nThis pass is available for organisations with an existing exhibitor or sponsorship package and provides access for one additional delegate. \nPackage includes: \n\nAccess to all conference presentations\nInvitation to the ESACT-UK conference dinner\nLunches and tea/coffee breaks throughout the conference\n\n  \nPlease note: Accommodation is not included in this pass. \n\n  \n\n \n\n \n \n \n\n \n\n\n \n\n\n\n Tickets\n\n \n \n \n The numbers below include tickets for this event already in your cart. Clicking "Get Tickets" will allow you to edit any existing attendee information as well as change ticket quantities. \n\n\n \n \n \n \n Tickets are no longer available \n\n\n \n \n \n\n \n \n\n \n \n\n\n\n \n\n \n\n\n \n \n The 36th ESACT-UK Annual Conference will be held at the Leonardo Royal Hotel Oxford (Formerly Jurys Inn)\, Oxford\, UK on the 7th and 8th January 2026. This year\, our exciting agenda will cover Engineering Biology Platforms\, integration of AI/ML in Bioprocess Development\, Translational Bioprocessing and Biopharmaceutical Development & Manufacturing. We will also host a Career Development Workshop with a focus on careers and skills. And of course\, we will have our Early Careers Session showcasing work of the Early Career Researchers from the ESACT-UK community. \nThe 2026 delegate conference registration cost includes: \n– Networking Session and Conference dinner on 7th January \n– Accommodation at the Leonardo Royal Hotel Oxford\, Oxford on 7th January (please opt out during registration if accommodation is not required) \nBook your tickets early to take advantage of our early bird rates. Early bird registration rates are available until Friday 28th November 2025. \nESACT-UK members will receive discounted registration rates (£100 discount for members will be applied at the checkout on provision of the discount code). To receive your unique code to take advantage of this offer\, please use the ‘Contact Us’ page and request the code via the Secretary. \nIf you would like to take advantage of a group booking (discounts can be applied)\, please get in touch via the ‘Contact Us’ page.  \nIf you would like to become an ESACT-UK member to take advantage of the discounted rates\, or you would like to contact the ESACT-UK committee for any queries related to registration or bursary applications please follow this link. \nWe look forward to welcoming you to our event in January! \n \n \n\n \n \n \n\n \n\n\n \n\n\n\n Tickets\n\n \n \n \n The numbers below include tickets for this event already in your cart. Clicking "Get Tickets" will allow you to edit any existing attendee information as well as change ticket quantities. \n\n\n \n \n \n \n Tickets are no longer available \n\n\n \n \n \n\n \n \n\n \n \n\n\n\n \n\n \n\n\n \n \n\n\n \n \n \n \n \n \n \n \n \n \n \n Leonardo Royal Hotel Oxford (Formerly Jurys Inn) \n \n \n \n\nGodstow Rd\, Wolvercote\n \n \n Oxford\,\n\n Oxfordshire\n\n OX2 8AL\n\n United Kingdom\n\n\n\n\n + Google Map \n\n\n \n \n +44 87 04100800 \n \n\n\n \n View Venue Website \n\n\n\n \n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n Add to calendar \n \n \n\n \n \n \n Google Calendar\n\n \n iCalendar\n\n \n Outlook 365\n\n \n Outlook Live\n\n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n 35th Annual Meeting ESACT-UK 2025 URL:https://www.esactuk.org.uk/event/36th-annual-meeting-esact-uk-2026/ LOCATION:Leonardo Royal Hotel Oxford (Formerly Jurys Inn)\, Godstow Rd\, Wolvercote\, Oxford\, Oxfordshire\, OX2 8AL\, United Kingdom ATTACH;FMTTYPE=image/jpeg:https://www.esactuk.org.uk/wp-content/uploads/2025/06/764991_219-scaled.jpg END:VEVENT END:VCALENDAR